TGFB1 and depressive symptom measurement: It is necessary in mediating microglial quiescence, while suppression of TGFβ1 expression and signaling is a commonality across Alzheimer’s Disease (human and mouse models), amyotrophic lateral sclerosis, multiple sclerosis [10], and depression [54,55].